HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF)

Clinical trials for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF) explained in plain language.

Never miss a new study

Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF) trials appear

Sign up with your email to follow new studies for HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Massive study reveals who gets key heart failure drugs

Knowledge-focused Completed

This study looked back at the medical records of over 13,600 heart failure patients in France from 2021 to 2024. It tracked how often doctors prescribed a specific type of medication called SGLT2 inhibitors. The goal was to understand prescription trends and what factors influenc…

Matched conditions: HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF)

Sponsor: Satelia • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:34 UTC

HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF)

Get alerted when new HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION (HFMREF) trials appear

Massive study reveals who gets key heart failure drugs